Rankings
▼
Calendar
INDV Q4 2021 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena
INDV
Indivior Pharmaceuticals Inc
$4B
Q4 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$223M
Gross Profit
$184M
82.5% margin
Operating Income
$45M
20.2% margin
Net Income
$36M
16.1% margin
EPS (Diluted)
$0.25
Cash Flow
Operating Cash Flow
$160M
Free Cash Flow
$158M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.8B
Total Liabilities
$1.6B
Stockholders' Equity
$203M
Cash & Equivalents
$1.1B
← FY 2021
All Quarters
Q1 2022 →
